Sanara Medtech Inc (NASDAQ: SMTI) stock closed at $34.06 on 5/15/24 after a major increase of 14.1%. Moreover, trading volume in this advance was exceptionally high at 220% of normal. The stock has performed in line with the market over the last nine months and has risen 1.7% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, SMTI is expected to continue to be a modest Value Eraser.
Sanara Medtech has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Sanara Medtech has a neutral Power Rating of 48 but a very low Appreciation Score of 6, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment